👀 Ones to watch: The MOST undervalued stocks to buy right nowSee Undervalued Stocks

China daily local COVID cases hit two-year high of over 1,500

Published 03/12/2022, 04:03 AM
Updated 03/12/2022, 06:30 AM
© Reuters. Residents line up outside a nucleic acid testing site of a hospital, following cases of the coronavirus disease (COVID-19), in Shanghai, China March 11, 2022. China Daily via REUTERS

By Brenda Goh

SHANGHAI (Reuters) -Mainland China reported more than 1,500 new local COVID-19 infections on Saturday, the most since the first nationwide outbreak in early 2020, as the Omicron variant prompted Beijing to introduce self-testing kits for the first time.

China's current case count is far fewer than those of many other countries, but the growing number could complicate Beijing's "dynamic-clearance" ambition to suppress contagion as quickly as possible.

The National Health Commission on Saturday said it had found 476 locally transmitted cases for Friday, including five people initially classified as asymptomatic who developed symptoms later.

There were 1,048 domestically transmitted asymptomatic infections, which China does not classify as confirmed cases, up from 703 a day earlier.

Beijing has ordered its localities to stick to the "dynamic clearing" policy and to prevent a large-scale rebound, prompting several cities to take measures such as cancelling group events, launching rounds of mass testing and cutting face-to-face classes in school.

At the same time the country is tweaking its testing regime in response to the spread of the Omicron variant, after having in the past two years required medical workers to swab members of the public using nucleic acid tests that require labs to process samples.

Health authorities said they would allow the general public to buy such kits in stores and online for the first time and on Saturday they approved five COVID-19 antigen kits made by local companies to be used for self-testing.

"In order to deal with how Omicron spreads, we need to promote a model of antigen screening and nucleic acid tests, enable the public to purchase tests by themselves, which is conducive to early detection," Chinese Vice Premier Sun Chunlan was quoted by state broadcaster CCTV as telling a government meeting on Saturday.

The capital of Beijing was among cities that took steps to tighten measures. The city government said that people entering the city should take nucleic acid tests and avoid joining in group meals or gatherings in the first seven days.

In the financial hub of Shanghai, the Disneyland resort said it would reduce its guest capacity and from Sunday require visitors to present negative nucleic acid test results taken within 24 hours.

The venue for the Canton Fair, China's oldest and biggest trade fair, in the southern province of Guangzhou has been temporarily closed as it was recently visited by a suspected confirmed case, local authorities said.

© Reuters. Residents line up outside a nucleic acid testing site of a hospital, following cases of the coronavirus disease (COVID-19), in Shanghai, China March 11, 2022. China Daily via REUTERS

The northeastern province of Jilin said on Saturday it had dismissed the mayor of Jilin city and a district head in the capital, Changchun. The province has been one of the hardest-hit regions in the latest outbreak.

Changchun has ordered all but essential businesses to halt operations and banned its 9 million residents from leaving their residential compounds for non-essential reasons. Similar measures have been applied in urban areas of Jilin city.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.